Sotera Health [SHC] vs Charles River [CRL] Detailed Stock Comparison

Sotera Health Company

NASDAQ
Loading...

Charles River Laboratories International, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sotera Health Company wins in 11 metrics, Charles River Laboratories International, Inc. wins in 9 metrics, with 0 ties. Sotera Health Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sotera Health Company Charles River Laboratories International, Inc. Better
P/E Ratio (TTM) 57.70 681.33 Sotera Health Company
Price-to-Book Ratio 7.31 2.61 Charles River Laboratories International, Inc.
Debt-to-Equity Ratio 375.56 81.95 Charles River Laboratories International, Inc.
PEG Ratio 0.29 20.54 Sotera Health Company
EV/EBITDA 11.50 12.23 Sotera Health Company
Profit Margin (TTM) 6.70% -3.60% Sotera Health Company
Operating Margin (TTM) 35.75% 4.51% Sotera Health Company
EBITDA Margin (TTM) 35.75% 4.51% Sotera Health Company
Return on Equity 15.42% -4.23% Sotera Health Company
Return on Assets (TTM) 8.18% 4.24% Sotera Health Company
Free Cash Flow (TTM) $149.18M $518.49M Charles River Laboratories International, Inc.
1-Year Return 27.78% 33.24% Charles River Laboratories International, Inc.
Price-to-Sales Ratio (TTM) 3.82 2.06 Charles River Laboratories International, Inc.
Enterprise Value $6.36B $10.72B Charles River Laboratories International, Inc.
EV/Revenue Ratio 5.47 2.67 Charles River Laboratories International, Inc.
Gross Profit Margin (TTM) 54.68% 31.15% Sotera Health Company
Revenue per Share (TTM) $4 $81 Charles River Laboratories International, Inc.
Earnings per Share (Diluted) $0.27 $-2.90 Sotera Health Company
Beta (Stock Volatility) 1.88 1.62 Charles River Laboratories International, Inc.
Short % of Float 5.18% 10.71% Sotera Health Company

Sotera Health Company vs Charles River Laboratories International, Inc. Stock Performance Analysis

Loading Price Chart...

SHC
CRL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sotera Health Company1.96%-1.74%-0.78%-2.74%-9.32%-13.68%
Charles River Laboratories International, Inc.3.29%9.35%4.38%2.38%-2.60%-11.14%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sotera Health Company27.78%5.89%-37.69%-37.69%-37.69%-37.69%
Charles River Laboratories International, Inc.33.24%-9.95%-46.35%110.50%383.44%347.52%

Performance & Financial Health Analysis: Sotera Health Company vs Charles River Laboratories International, Inc.

MetricSHCCRL
Market Information
Market Cap i$4.44B$8.28B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i2,339,870761,885
90 Day Avg. Volume i2,792,153865,618
Last Close$15.57$185.79
52 Week Range$10.80 - $19.85$138.81 - $228.88
% from 52W High-21.56%-18.83%
All-Time High$30.38 (Mar 15, 2021)$460.21 (Sep 20, 2021)
% from All-Time High-48.75%-59.63%
Growth Metrics
Quarterly Revenue Growth0.05%-0.01%
Quarterly Earnings Growth1.83%-0.01%
Financial Health
Profit Margin (TTM) i0.07%-0.04%
Operating Margin (TTM) i0.36%0.05%
Return on Equity (TTM) i0.15%-0.04%
Debt to Equity (MRQ) i375.5681.95
Cash & Liquidity
Book Value per Share (MRQ)$2.13$64.30
Cash per Share (MRQ)$1.21$4.34
Operating Cash Flow (TTM) i$287.20M$737.65M
Levered Free Cash Flow (TTM) i$236.80M$572.38M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Sotera Health Company vs Charles River Laboratories International, Inc.

MetricSHC (Apr 26, 2026)CRL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i57.70681.33
Forward P/E i14.8913.59
PEG Ratio i0.2920.54
Price to Sales (TTM) i3.822.06
Price to Book (MRQ) i7.312.61
Market Capitalization
Market Capitalization i$4.44B$8.28B
Enterprise Value i$6.36B$10.72B
Enterprise Value Metrics
Enterprise to Revenue i5.472.67
Enterprise to EBITDA i11.5012.23
Risk & Other Metrics
Beta i1.881.62
Book Value per Share (MRQ) i$2.13$64.30

Financial Statements Comparison: Sotera Health Company vs Charles River Laboratories International, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSHC (2025)CRL (2025)
Revenue/Sales i1.16B4.02B
Cost of Goods Sold i518.08M2.69B
COGS % of Revenue i44.5%67.0%
Gross Profit i645.53M1.32B
Gross Margin i55.5%33.0%
Research & Development iN/AN/A
Operating Income (EBIT) i362.03M401.14M
Operating Margin i31.1%10.0%
EBITDA i507.29M786.81M
EBITDA Margin i43.6%19.6%
Pre-Tax Income i147.51M-99.50M
Pre-Tax Income % of Revenue i12.7%-2.5%
Income Tax i69.56M42.66M
Income Tax % of Revenue i6.0%1.1%
Net Income (Profit) i77.95M-142.16M
Profit Margin i6.7%-3.5%

Balance Sheet & Liquidity Metrics

MetricSHC (2025)CRL (2025)
Cash & Equivalents i344.62M213.77M
Total Current Assets i613.41M1.45B
Total Current Assets % of Revenue i52.7%36.0%
Total Current Liabilities i249.58M1.12B
Total Current Liabilities % of Revenue i21.4%27.9%
Long-Term Debt i2.25B2.57B
Long-Term Debt % of Revenue i193.4%64.0%
Total Shareholders Equity i606.04M3.21B
Retained Earnings i-532.09M1.39B
Retained Earnings % of Revenue i-45.7%34.6%
Property, Plant & Equipment i41.32M361.42M

Cash Flow Statement Comparison

MetricSHC (2025)CRL (2025)
Operating Cash Flow i276.60M194.22M
Operating Cash Flow % of Revenue i23.8%4.8%
Capital Expenditures i-138.02MN/A
Free Cash Flow i149.18M518.49M
FCF Margin i12.8%12.9%
Debt Repayment i-86.10M-1.35B
Common Stock Repurchase iN/A-360.67M

Short Interest & Institutional Ownership Analysis

MetricSHCCRL
Shares Short i12.81M4.59M
Short Ratio i4.405.18
Short % of Float i5.18%10.71%
Shares Outstanding i284.37M49.22M
Float Shares i191.73M48.66M
% Held by Insiders i2.32%0.85%
% Held by Institutions i85.40%110.31%
% Held by Public i12.28%-11.16%

Dividend Analysis & Yield Comparison: Sotera Health Company vs Charles River Laboratories International, Inc.

MetricSHCCRL
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A